References
- Alkjaersig N., Fletcher A. P., De Ziegler D., Steingold K. A., Meldrum D. R., Judd H. L. Blood coagulation in postmenopausal women given estrogen treatment: comparison of transdermal and oral administration. Journal of Laboratory and Clinical Medicine 1988; 111: 224–228
- Bauer K. A., Rosenberg R. D. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood 1987; 70: 343–350
- Boisclair M. D., Ireland H., Lane D. A. Assessment of hypercoagulability states by measurement of activation fragments and peptides. Blood Reviews 1990; 4: 25–40
- Boston Collaborative Drug Surveillance Program, Boston University, Medical Centre. Surgically confirmed gallbladder disease, venous thromboembolism and breast tumours in relation to postmenopausal estrogen therapy. A report from New England Journal of Medicine 1974; 290: 15–19
- Caine Y. G., Bauer K. A., Barzegar S., ten Cate H., Sacks F. M., Walsh B. W., Schiff I., Rosenberg R. D. Coagulation activation following estrogen administration to postmenopausal women. Thrombosis and Haemostasis 1992; 68: 392–395
- Chetkowski R. J., Meldrum D. R., Steingold K. A., Randle D., Lu J. K., Eggena P., Hershman J. M., Alkjaersig N. K., Fletcher A. P., Judd H. L. Biological effects of transdermal estradiol. New England Journal of Medicine 1986; 314: 1615–1620
- Devor M., Barrett-Connor E., Renvall M., Feigal D., Ramsdell J. Estrogen replacement therapy and the risk of venous thrombosis. American Journal of Medicine 1992; 92: 275–282
- Fox J., George A. J., Newton J. R., Parsons A. D., Stuart G. K., Stuart J., Sturdee D. W. Effect of transdermal hormone replacement therapy on the haemostatic balance of menopausal women. Maturitas 1993; 18: 55–64
- Garnett T., Studd J. W. W., Henderson A., Watson N., Savvas M., Leather A. Hormone implants and tachyphylaxis. British Journal of Obstetrics and Gynaecology 1990; 97: 917–921
- Hunt K., Vessey M., McPherson K. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. British Journal of Obstetrics and Gynaecology 1990; 97: 1080–1086
- Pelzer H., Schwarz A. Determination of human thrombin-antithrombin III complex in plasma with an enzyme linked immunosorbent assay. Thrombosis and Haemostatis 1988; 59: 101–106
- Wolf P. H., Madam J. H., Finucane F. F., Higgins M., Kleinman J. C. Reduction in cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort. American Journal of Obstetrics and Gynaecology 1991; 164: 489–494
- Yoong A., Rugman F. P., Hay C. R.M. Hormone implants and tachyphylaxis. British Journal of Obstetrics and Gynaecology 1991; 98: 500–501